|
US4431657A
(en)
*
|
1982-05-24 |
1984-02-14 |
Ayerst, Mckenna & Harrison Inc. |
Analgesic compositions consisting of 2H-benzothieno[3,2-c]pyrazol-3-amine derivatives
|
|
KR20010086657A
(ko)
*
|
2000-03-02 |
2001-09-15 |
성재갑 |
아미노인다졸 유도체 및 이를 함유하는 싸이클린 의존키나아제 저해제 조성물
|
|
US7473691B2
(en)
*
|
2000-09-15 |
2009-01-06 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compounds useful as protein kinase inhibitors
|
|
US6660731B2
(en)
|
2000-09-15 |
2003-12-09 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compounds useful as protein kinase inhibitors
|
|
WO2002022604A1
(en)
*
|
2000-09-15 |
2002-03-21 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compounds useful as protein kinase inhibitors
|
|
ZA200301701B
(en)
*
|
2000-09-15 |
2004-03-01 |
Vertex Pharma |
Pyrazole compounds useful as protein kinase inhibitors.
|
|
SI1318997T1
(sl)
*
|
2000-09-15 |
2006-12-31 |
Vertex Pharma |
Pirazolne spojine, uporabne kot inhibitorji protein-kinaze
|
|
CA2432131C
(en)
*
|
2000-12-21 |
2008-07-08 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compounds useful as protein kinase inhibitors
|
|
KR100406634B1
(ko)
*
|
2001-03-12 |
2003-11-20 |
주식회사 엘지생명과학 |
3,5-디아미노인다졸 유도체, 그의 제조방법 및 사이클린의존성 키나아제 저해제로서의 그의 용도
|
|
BR0212841A
(pt)
|
2001-09-26 |
2004-08-03 |
Pharmacia Italia Spa |
Derivado ativo de aminoindazole como inibidores de cinase, processo para sua preparação e composições farmacêuticas que os contém
|
|
JP4656838B2
(ja)
*
|
2002-02-06 |
2011-03-23 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
Ｇｓｋ−３の阻害剤として有用なヘテロアリール化合物
|
|
FR2836915B1
(fr)
*
|
2002-03-11 |
2008-01-11 |
Aventis Pharma Sa |
Derives d'aminoindazoles, procede de preparation et intermediaires de ce procede a titre de medicaments et compositions pharmaceutiques les renfermant
|
|
US20040009981A1
(en)
|
2002-03-15 |
2004-01-15 |
David Bebbington |
Compositions useful as inhibitors of protein kinases
|
|
JP4751063B2
(ja)
|
2002-05-17 |
2011-08-17 |
ファイザー イタリア ソシエタ ア レスポンサビリタ リミタータ |
キナーゼ阻害剤として活性のアミノインダゾール誘導体、それらの調製方法、及びそれらを含む薬学的組成物
|
|
MY141867A
(en)
|
2002-06-20 |
2010-07-16 |
Vertex Pharma |
Substituted pyrimidines useful as protein kinase inhibitors
|
|
NZ538426A
(en)
|
2002-08-02 |
2007-05-31 |
Vertex Pharma |
Pyrazole compositions useful as inhibitors of glycogen synthase kinase-3 (GSK-3)
|
|
US7199119B2
(en)
*
|
2002-10-31 |
2007-04-03 |
Amgen Inc. |
Antiinflammation agents
|
|
US7601718B2
(en)
|
2003-02-06 |
2009-10-13 |
Vertex Pharmaceuticals Incorporated |
Compositions useful as inhibitors of protein kinases
|
|
AU2004297235A1
(en)
*
|
2003-12-04 |
2005-06-23 |
Vertex Pharmaceuticals Incorporated |
Quinoxalines useful as inhibitors of protein kinases
|
|
DE102004005172A1
(de)
*
|
2004-02-02 |
2005-08-18 |
Aventis Pharma Deutschland Gmbh |
Indazolderivate als Inhibitoren der Hormon Sensitiven Lipase
|
|
EP1917259B1
(en)
|
2005-08-18 |
2012-01-25 |
Vertex Pharmaceuticals Incorporated |
Pyrazine kinase inhibitors
|
|
JP5249770B2
(ja)
|
2005-11-03 |
2013-07-31 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
キナーゼインヒビターとして有用なアミノピリジン
|
|
NZ571705A
(en)
*
|
2006-04-14 |
2012-03-30 |
Abbott Lab |
Process for the preparation of indazolyl ureas that inhibit vanilloid subtype 1 (VR1) receptors
|
|
JP2010509231A
(ja)
|
2006-11-02 |
2010-03-25 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
プロテインキナーゼの阻害剤として有用なアミノピリジンおよびアミノピリミジン
|
|
NZ577768A
(en)
|
2006-12-19 |
2012-01-12 |
Vertex Pharma |
Aminopyrimidines useful as inhibitors of protein kinases
|
|
MX2009009590A
(es)
|
2007-03-09 |
2009-11-10 |
Vertex Pharma |
Aminopirimidinas utiles como inhibidores de proteinas cinasas.
|
|
AU2008226461A1
(en)
|
2007-03-09 |
2008-09-18 |
Vertex Pharmaceuticals Incorporated |
Aminopyridines useful as inhibitors of protein kinases
|
|
ES2374335T3
(es)
|
2007-03-09 |
2012-02-15 |
Vertex Pharmaceuticals Incorporated |
Aminopirimidinas útiles como inhibidores de proteína quinasas.
|
|
CN101679386A
(zh)
|
2007-04-13 |
2010-03-24 |
沃泰克斯药物股份有限公司 |
可用作激酶抑制剂的氨基嘧啶类化合物
|
|
MX2009011812A
(es)
|
2007-05-02 |
2010-01-14 |
Vertex Pharma |
Aminopirimidinas utiles como inhibidores de cinasa.
|
|
MX2009011811A
(es)
*
|
2007-05-02 |
2010-01-14 |
Vertex Pharma |
Aminopirimidinas utiles como inhibidores de cinasa.
|
|
MX2009011810A
(es)
*
|
2007-05-02 |
2010-01-14 |
Vertex Pharma |
Tiazoles y pirazoles utiles como inhibidores de cinasa.
|
|
CN101687852A
(zh)
*
|
2007-05-24 |
2010-03-31 |
沃泰克斯药物股份有限公司 |
可用作激酶抑制剂的噻唑类和吡唑类化合物
|
|
CA2694499A1
(en)
|
2007-07-31 |
2009-02-05 |
Vertex Pharmaceuticals Incorporated |
Process for preparing 5-fluoro-1h-pyrazolo [3, 4-b] pyridin-3-amine and derivatives thereof
|
|
JP2012501971A
(ja)
*
|
2008-09-03 |
2012-01-26 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
共結晶および共結晶を含む薬学的処方物
|
|
DE102009004245A1
(de)
|
2009-01-09 |
2010-07-15 |
Bayer Schering Pharma Aktiengesellschaft |
Neue anellierte, Heteroatom-verbrückte Pyrazol- und Imidazol-Derivate und ihre Verwendung
|
|
SMT201800202T1
(it)
|
2012-07-24 |
2018-05-02 |
Bial Portela & Ca Sa |
Composti di urea e loro uso come inibitori enzimatici
|
|
BR112015001769A2
(pt)
*
|
2012-07-27 |
2017-08-22 |
Bial Portela & Ca Sa |
Processo para a síntese de compostos de ureia substituída
|
|
CA2918993C
(en)
|
2013-07-24 |
2021-08-24 |
Bial - Portela & Ca, S.A. |
Imidazolecarboxamides and their use as faah inhibitors
|